This document discusses techniques for treating complex tibial chronic total occlusions (CTOs). It notes that tibial CTOs are more challenging than superficial femoral artery occlusions due to calcification, limited re-entry options, and difficulty visualizing distal vessels. New guidewires, support catheters, re-entry devices, and CTO crossing devices can help cross tibial CTOs. Acute procedural success can be achieved with angioplasty, cryoplasty, atherectomy, drug-coated balloons, or drug-eluting stents, but long-term patency with angioplasty alone is poor. Novel techniques and devices have increased the number of previously untreatable tibial C
Updated HTO vs UniKnee for Postgraduate Orthopaedic Course in Newcastle March...
Defero Test 2
1. Complex Tibial CTO Techniques Tony Das MD FACC Director, Peripheral Interventions Dallas, Texas
2. Das Disclosures 2010 Abbott Vascular Research/Education Angioslide Consultant Bard Vascular Education Boston Scientific Research Cordis Endovascular Consultant/Education/Research CSI Consultant/Equity/Education WL Gore Education IDEV Consultant/Equity/Education Spectranetics Consultant/Education VIVA Board member/Grant support Educational grafts consist of PVD and Carotid proctorship support
4. How are Infrapopliteal CTO’s different than SFA occlusions? Often calcified Unable to reliably use subintimal technique Re-entry options are limited More emphasis on true lumen crossing Angled takeoffs of AT and PT Distal vessels often not well seen http://youtu.be/o2aXxrbIeFI
5. RIM Catheter Support or Glidecatheter Crossover sheath 65-90 cm Direct visualization to the foot Direct Local Imaging
7. Complex Tibial CTO Techniques Guidewires and support catheters 0.014in coronary CTO wires/ Quickcross Re-entry devices Differential dissection CTO devices for BTK PTA/Cryoplasty/Laser/Atherectomy/Stent Tibial retrograde options
8. Tibial CTO with PTA only Leipzig Registry data. A. Schmidt et al. Catheter CardiovascInterv 2010 Low patency rates with PTA alone: Restenosis 68.8% @3 mo
9. Drug Eluting Balloon BTKLeipzig Trial Results InPactAmphirion Paclitaxel eluting balloon 104 patients/ 109 limbs Mean lesion length: 173 +/- 87 mm
11. CLI and Cryoplasty The BTK CHILL Trial was a prospective, multi-center registry N= 111 patients with CLI treated with cryoplasty. 67% Diabetics 35% Occlusions Procedural success was 97%. Limb salvage at 6-months was 93%. Das T, et al. .J EndovascTher. 2007 Dec;14(6):753-62.
23. BTK New CTO Devices 65 y/o M with CAD, DM, non healing ulcer R. LE for 4 months (lateral 4th and 5th toes) ABI: 0.3R and 0.7L at rest Referred for angiography CTO SFA, Popliteal and Tibial
26. The CROSSER™ System Generator Converts AC power into high frequency current Piezoelectric crystals within the Transducer convert high frequency current into vibrational energy Foot Switch activates System CROSSER Catheter Nitinol core wire transmits mechanical vibration to the metal tip of the Catheter at 20,000 cycles/second 20 micron amplitude (stroke depth)
37. BTK Re-entry TechniqueTibial occlusion with ulcer 78 year old M w/ history of Occluded Fem-pop with non-healing ulcer No obvious direct runoff vessel to the foot Ulcer on 3rd and 4th toes ABI of 0.3 and toe pressure of 30 mmHg
39. Trapped wire in subintimalspace BTK What to do next? A. Continue subintimal tract B. Consider changing to different wire C. Considering other devices Frontrunner Outback Crosser Other? D. Abort Case E. PTA SFA/popliteal
46. Summary Previously unapproachable tibial CTO’s can be addressed novel wires, alternative access routes, newer true lumen crossing devices, and CTO re-entry devices Acute procedural success includes PTA, cryoplasty, possibly atherectomy, and consideration for DEB and stents (DES) Long-term results for PTA alone are dismal, but may lead to wound healing Very few cases are truly “undoable”